131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors
{{output}}
Treatment with (131)I-metaiodobenzylguanidine (MIBG) has been introduced to the management of neuroendocrine tumors (NET) nearly 30 years ago. It provides efficient internal radiotherapy of chromaffin tumors (neuroblastoma, pheochromocytoma, and paraganglioma)... ...
